Anand Sonia S, Razak Fahad, Vuksan Vlad, Gerstein Hertzel C, Malmberg Klas, Yi Qilong, Teo Koon K, Yusuf Salim
Department of Medicine, Division of Cardiology and Population Health Research Institute, McMaster University, Ontario, Canada.
Diabetes Care. 2003 Feb;26(2):290-6. doi: 10.2337/diacare.26.2.290.
Identifying individuals who have elevated glucose concentrations is important for clinicians so that preventive strategies can be invoked, and it is useful for researchers who study associations between elevated glucose and adverse health outcomes. These methods should be applicable worldwide across different ethnic groups. Therefore, the objective of our analysis was to determine whether using the fasting glucose and HbA(1c) together could improve the classification of individuals with impaired glucose tolerance and diabetes in a multiethnic cohort randomly assembled in Canada.
We determined the optimum diagnostic criteria to identify people with abnormal glucose tolerance using fasting plasma glucose, 2-h post-glucose load plasma glucose, and HbA(1c) in 936 Canadians of South Asian, Chinese, and European descent.
The sensitivity of the American Diabetes Association (ADA) criteria to diagnose diabetes compared with the World Health Organization definitions was poor at 48.3% (95% confidence interval [CI] 35.7-61.0). Using a receiver operator characteristic curve, the optimum combined cut-point using fasting glucose and HbA(1c) to diagnose diabetes was a fasting glucose > or =5.7 mmol/l and an HbA(1c) > or =5.9%. These cut-points were associated with a sensitivity and specificity of 71.7% (60.3-83.1) and 95.0% (93.5-96.4), respectively, a positive likelihood ratio (LR) of 14.3 (9.6-19.0), and a negative LR of 0.3 (0.2-0.4). Significant ethnic variation in the sensitivity and specificity of this approach was observed: 47.4% (24.9-69.8) and 97.6% (95.9-99.4) among Europeans, 78.6% (57.1-100) and 95.9% (93.6-98.2) among Chinese, and 85.2% (71.8-98.6) and 91.3% (88.1-94.6) among South Asians, respectively. Participants with impaired glucose tolerance could not be identified reliably using the fasting glucose or HbA(1c) alone or in combination.
The sensitivity of the ADA criteria to diagnose diabetes is low, and there is substantial variation between ethnic groups. Fasting glucose and HbA(1c) may be used together to improve the identification of individuals who have diabetes, allowing clinicians to streamline the use of the oral glucose tolerance test.
识别血糖浓度升高的个体对于临床医生而言很重要,这样可以采取预防策略,对于研究血糖升高与不良健康结局之间关联的研究人员也很有用。这些方法应适用于全球不同种族群体。因此,我们分析的目的是确定在加拿大随机组建的多民族队列中,联合使用空腹血糖和糖化血红蛋白(HbA₁c)是否能改善糖耐量受损和糖尿病个体的分类。
我们在936名南亚、中国和欧洲裔加拿大人中,使用空腹血糖、葡萄糖负荷后2小时血糖和糖化血红蛋白(HbA₁c)确定了识别糖耐量异常人群的最佳诊断标准。
与世界卫生组织的定义相比,美国糖尿病协会(ADA)诊断糖尿病标准的敏感性较差,为48.3%(95%置信区间[CI] 35.7 - 61.0)。使用受试者工作特征曲线,联合空腹血糖和糖化血红蛋白(HbA₁c)诊断糖尿病的最佳切点是空腹血糖≥5.7 mmol/L且糖化血红蛋白(HbA₁c)≥5.9%。这些切点的敏感性和特异性分别为71.7%(60.3 - 83.1)和95.0%(93.5 - 96.4),阳性似然比(LR)为14.3(9.6 - 19.0),阴性似然比为0.3(0.2 - 0.4)。观察到该方法在敏感性和特异性方面存在显著的种族差异:欧洲人中为47.4%(24.9 - 69.8)和97.6%(95.9 - 99.4),中国人中为78.6%(57.1 - 100)和95.9%(93.6 - 98.2),南亚人中为85.2%(71.8 - 98.6)和91.3%(88.1 - 94.6)。单独或联合使用空腹血糖或糖化血红蛋白(HbA₁c)无法可靠地识别糖耐量受损的参与者。
ADA诊断糖尿病标准的敏感性较低,且种族之间存在显著差异。空腹血糖和糖化血红蛋白(HbA₁c)可联合使用以改善糖尿病个体的识别,使临床医生能够简化口服葡萄糖耐量试验的使用。